Literature DB >> 16822907

Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study.

Isabel Illa, Carolina de la Torre, Ricardo Rojas-Garcia, Antoni Altes, Rafael Blesa, Jordi Sierra, Eduard Gallardo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16822907     DOI： 10.1182/blood-2006-01-0186

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

2.  Scleromyxedema: An Atypical Case.

Authors:  Emy Thomas; Anisha George; Divya Deodhar; Mary John
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

Review 3.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

Review 4.  Scleroderma-like fibrosing disorders.

Authors:  Francesco Boin; Laura K Hummers
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

5.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11

6.  Scleromyxedema: a rare disorder and its treatment difficulties.

Authors:  Sandra Koleta Koronowska; Agnieszka Osmola-Mańkowska; Oliwia Jakubowicz; Ryszard Zaba
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.